Tag Archives: Heartburn Drug
-
-
Recalled Zantac OTC Brand Return To Market With Generic Pepcid Ingredient
-
Increased Risk of Bladder Cancer From Zantac Seen in New Study
-
Following Zantac Problems and Recalls, GlaxoSmithKline Sells Manufacturing Plant In India For Fraction Of Value
-
Direct Filing of Zantac Class Action Lawsuits Permitted in Federal MDL
-
Amended Class Action Lawsuits Over Zantac Recalls Filed in MDL
-
Zantac Risks Inherent in Heartburn Drug, Producing Cancer-Causing Chemical in Human Body: Study
-
Motion Filed To Remand Zantac Recall Lawsuits to California State Court
-
Types of Cancer Linked to Zantac That Will Be Supported By Export Reports Outlined By Plaintiffs Leadership in MDL
-
Motion to Dimiss Generic Zantac Lawsuits Granted on Preemption Grounds